Deciphering the molecular basis of human cardiovascular disease through network biology

Stephen Y Chan1, Kevin White, Joseph Loscalzo

  • 1Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.

Insights

Network medicine offers a new approach to understanding complex cardiovascular diseases by analyzing interconnected biological pathways. This framework aids in discovering new genes and improving drug development for personalized therapies.

Area of Science:

  • Cardiovascular research
  • Systems biology
  • Genomics

Background:

  • Cardiovascular diseases arise from complex interactions within multiple pathobiological pathways, not single molecular defects.
  • The postgenomic era provides a framework for understanding cellular molecular interactions and their complexity.
  • Network approaches are increasingly used to comprehend disease-influencing interconnections.

Purpose of the Study:

  • Introduce fundamental concepts of network medicine.
  • Explore the feasibility of network-based methods for cardiovascular disease.
  • Assess the potential impact of network medicine on predicting and ameliorating cardiovascular disease.

Main Methods:

  • Review of network medicine principles.
  • Analysis of network-based approaches in cardiovascular research.
  • Exploration of potential applications in disease prediction and therapy.

Main Results:

  • Network medicine has yielded discoveries of novel disease genes and pathways.
  • It has improved mechanisms for rational drug development.
  • Network approaches offer a comprehensive understanding of disease interconnections.

Conclusions:

  • Evolving methodologies in network medicine can better capture human pathogenesis complexity.
  • Network medicine has the potential to redefine personalized disease classification.
  • It may lead to more effective personalized therapies for cardiovascular conditions.
Abstract

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...